Skip to content

Self-Efficacy in Weight Loss Treatment

Self-Efficacy in Weight Loss Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00896194
Acronym
SELF
Enrollment
120
Registered
2009-05-11
Start date
2009-05-31
Completion date
2013-04-30
Last updated
2015-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight, Obesity

Keywords

Overweight, Obesity, Self-Efficacy, Treatment Adherence

Brief summary

This randomized clinical trial of weight loss treatment will examine if adding personalized, one-on-one treatment session to standard behavioral group treatment will result in greater weight loss, less weight regain after weight loss, and better adherence to the treatment protocol. Everyone who enrolls in the study will receive information on healthy eating, how to increase their physical activity and develop healthy exercise habits and ways to change their eating so that they will lose weight. This information will be provided at evening group sessions. There will be a total of 20 group meetings over an 18-month period that will be held: * every week during the first month of the study, * every other week for the second month * once a month for months 3-12 * every 6 weeks for months 13-18 Participants in the self-efficacy group will also be asked to participate in one-on-one lifestyle counseling sessions with a study interventionist throughout the study. Everyone will be asked to complete questionnaires, two 24-hour dietary recalls over the phone, and have blood tests done every six months (at the beginning of the study, at 6, 12, and 18 months) a total of 4 times for the study.

Interventions

SBT consists of group counseling sessions where participants learn about healthy eating and physical activity. Participants are also given standard calorie goals, fat gram goals, and physical activity goals (minutes).

BEHAVIORALModified Standard Behavioral Intervention + Self-Efficacy

This group receives identical group intervention sessions. The goals (calories, fat grams, and physical activity minutes) are tailored to the individual's progress. Participants meet regularly with an interventionist for one-on-one lifestyle counseling.

Sponsors

Lora Burke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age 18 years or older * BMI \> 27 and \< 43 * willing to be randomized to one of the two treatment conditions * successful completion of screening requiring 5-day recording of food intake in a paper diary * have at least two risk factors for coronary heart disease, e.g., overweight or obese, hypertension, dyslipidemia, positive family history (first degree relative) NOTE: Although residing in Western Pennsylvania is not an explicit eligibility criterion, participants are asked to travel to the University of Pittsburgh frequently (weekly for the first month)

Exclusion criteria

* presence of a current serious illness or unstable condition requiring physician-supervised diet and exercise (e.g., diabetes, recent acute myocardial infarction) for which physician supervision of diet and physical activity prescription is needed * physical limitations precluding ability to engage in physical activity at moderate intensity * pregnancy or intention to become pregnant in the next 18 months * current treatment for a psychological disorder * reported alcohol intake \> 4 drinks/day * previous participation in a formal weight loss program within the past 5 years, e.g., Weight Watchers or a research program, or current use of weight loss medication * planned extended vacations, absences, or relocation within the next 18 months

Design outcomes

Primary

MeasureTime frame
Weight12 and 18 months post enrollment

Secondary

MeasureTime frame
Health-related quality of life12 and 18 months post enrollment
Adherence to treatment protocol12 and 18 months post enrollment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026